Healthpeak Properties (NYSE:DOC) Announces Earnings Results, Beats Estimates By $0.05 EPS

Posted by Brenda Bartman on Aug 5th, 2026

Healthpeak Properties (NYSE:DOC – Get Free Report) released its earnings results on Tuesday. The real estate investment trust reported $0.08 EPS for the quarter, topping the consensus estimate of $0.03 by $0.05, FiscalAI reports. The company had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the business earned $0.46 EPS. Healthpeak Properties updated its FY 2026 guidance to 1.730-1.770 EPS.

Healthpeak Properties Price Performance

Shares of DOC stock traded up $0.27 during trading hours on Wednesday, hitting $21.89. The company’s stock had a trading volume of 3,267,744 shares, compared to its average volume of 8,602,073. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The business has a fifty day moving average of $21.08 and a 200-day moving average of $18.73. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95. The stock has a market cap of $15.09 billion, a price-to-earnings ratio of 68.49, a P/E/G ratio of 3.36 and a beta of 1.01.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.6%. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds have recently modified their holdings of DOC. Integrated Wealth Concepts LLC increased its position in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after purchasing an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after acquiring an additional 63,930 shares in the last quarter. Woodline Partners LP lifted its holdings in shares of Healthpeak Properties by 41.3% during the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after acquiring an additional 17,279 shares in the last quarter. Brown Advisory Inc. increased its holdings in Healthpeak Properties by 3.1% in the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after purchasing an additional 1,415 shares in the last quarter. Finally, Qube Research & Technologies Ltd purchased a new position in Healthpeak Properties in the second quarter valued at about $3,117,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on DOC. Citigroup raised their target price on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Royal Bank Of Canada raised their price objective on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Evercore cut shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price for the company. in a report on Monday, May 11th. Finally, Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. According to MarketBeat, Healthpeak Properties has an average rating of “Hold” and a consensus price target of $20.62.

Check Out Our Latest Stock Analysis on Healthpeak Properties

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.